肝脏 ›› 2026, Vol. 31 ›› Issue (9): 1348-1354.

• 其他肝病 • 上一篇    下一篇

胆囊癌组织14-3-3θ、TIMP3表达及与患者临床病理特征、预后的关系

李强, 李颖, 刘星, 黄艳洁, 赵臣, 代建国   

  1. 075000 张家口 张家口市第一医院肝胆胰外科(李强,刘星,黄艳洁,代建国);
    075000 张家口 张家口市桥东区医院(李颖);
    075000 张家口 河北华奥医院(赵臣)
  • 收稿日期:2025-09-18 出版日期:2026-09-30 发布日期:2026-11-16
  • 通讯作者: 刘星,Email: xuxkx34@163.com
  • 基金资助:
    张家口市重点研发计划项目(2322070D)

The expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue and their relationship with clinical pathological features and prognosis of patients

Li Qiang1, Li Ying2, Liu Xing1, Huang Yanjie1, Zhao Chen3, Dai Jianguo1   

  1. 1. Department of Hepatobiliary Pancreatic Surgery, Zhangjiakou First Hospital, Zhangjiakou 075000, China;
    2. Qiaodong District Hospital, Zhangjiakou 075000,China;
    3. Hebei Huaao Hospital, Zhangjiakou 075000, China
  • Received:2025-09-18 Online:2026-09-30 Published:2026-11-16
  • Contact: Liu Xing,Email: xuxkx34@163.com

摘要: 目的 探讨胆囊癌组织中14-3-3θ、金属蛋白酶组织抑制因子(TIMP)3表达情况及与患者临床病理特征、预后的关系。方法 选取张家口市第一医院2020年3月—2021年6月收治的113例胆囊癌患者为研究对象。免疫组化法检测胆囊癌及其癌旁组织中14-3-3θ、TIMP3表达。采用Kaplan-Meier法绘制生存曲线,分析胆囊癌组织中14-3-3θ、TIMP3表达与患者预后的关系;采用多因素Cox回归分析模型筛选胆囊癌预后的影响因素。结果 与癌旁组织(32/113,28.32%)相比,胆囊癌组织中14-3-3θ阳性表达率(85/113,75.22%)较高(χ2=48.779,P<0.05),TIMP3阳性表达率(31/113,27.43%)较低(χ2=59.769,P<0.05)。胆囊癌组织中,14-3-3θ、TIMP3表达与分化程度(χ2=5.509、6.023)、TNM分期(χ2=8.203、7.636)有关(P<0.05)。113例胆囊癌患者3年总生存率为51.33%。与生存组[19/58,32.76%;10/58,17.24%;(61.62±11.48) U/mL;(80.45±13.16) U/mL]相比,死亡组低/未分化(35/55,63.64%)、TNM为Ⅲ期(27/55,49.09%)的占比以及糖类抗原(CA)-125[(84.51±13.95) U/mL]、CA19-9水平[(106.23±16.37) U/mL]均明显较高(P<0.05)。与生存组(38/85,44.71%)相比,死亡组胆囊癌组织中14-3-3θ阳性表达率(47/85,55.29%)较高(P<0.05),TIMP3阳性表达率(9/31,29.03%)较低(χ2=6.596,P<0.05)。多因素Cox回归分析显示,分化程度(HR=1.846)、TNM分期(HR=2.059)、14-3-3θ(HR=1.562)、TIMP3(HR=0.913)、CA-125(HR=1.781)、CA19-9(HR=1.906)与胆囊癌预后有关(P<0.05)。Kaplan-Meier分析显示,14-3-3θ阳性表达患者3年总生存率(44.71%)低于14-3-3θ阴性表达患者3年总生存率(71.43%)(Log Rank χ2=5.627,P=0.018);TIMP3阳性表达患者3年总生存率(70.97%)高于TIMP3阴性表达患者3年总生存率(43.90%)(Log Rank χ2=6.130,P=0.013)。结论 胆囊癌组织中14-3-3θ阳性表达率较高,TIMP3阳性表达率较低,胆囊癌组织中14-3-3θ、TIMP3表达情况与患者临床病理特征及预后均密切相关。

关键词: 胆囊癌, 临床病理特征, 预后, 14-3-3θ, 金属蛋白酶组织抑制因子3

Abstract: Objective To investigate the expression of 14-3-3θ and tissue inhibitor of metalloproteinase (TIMP) 3 in gallbladder cancer tissue and their relationship with clinical pathological features and prognosis of patients. Methods A total of 113 patients with gallbladder cancer admitted to Zhangjiakou First Hospital from March 2020 to June 2021 were regarded as the research subjects. Immunohistochemistry was applied to detect the expression of 14-3-3θ and TIMP3 in gallbladder cancer and its adjacent tissues. Kaplan-Meier curve was applied to analyze the relationship between the expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue and prognosis. Multivariate Cox regression was applied to analyze the factors influencing the prognosis of gallbladder cancer. Results Compared with adjacent tissues (32/113, 28.32%), the positive expression rate of 14-3-3θ (85/113, 75.22%) was higher in gallbladder cancer tissues (χ2=48.779, P<0.05), and the positive expression rate of TIMP3 (31/113, 27.43%) was lower (χ2=59.769, P<0.05). The expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue was related to differentiation degree (χ2=5.509, 6.023) and TNM staging (χ2=8.203, 7.636) (P<0.05). The three-year overall survival rate of 113 patients with gallbladder cancer was 51.33%. Compared with the survival group [19/58, 32.76%; 10/58, 17.24%; (61.62 ± 11.48) U/mL; (80.45 ± 13.16) U/mL], the proportions of low/undifferentiated (35/55, 63.64%) and TNM stage Ⅲ (27/55, 49.09%), as well as the levels of carbohydrate antigen (CA) -125 [(84.51 ± 13.95) U/mL] and CA 19-9 [(106.23 ± 16.37) U/mL] in the death group were significantly higher (P<0.05). Compared with the survival group (38/85, 44.71%), the death group had a higher positive expression rate of 14-3-3θ in gallbladder cancer tissue (47/85, 55.29%) (χ2=6.020, P<0.05), and a lower positive expression rate of TIMP3 (9/31, 29.03%) (χ2=6.596, P<0.05). Multivariate Cox regression analysis showed that The degree of differentiation (HR=1.846), TNM stage (HR=2.059), 14-3-3θ (HR=1.562), TIMP3 (HR=0.913), CA-125 (HR=1.781), and CA19-9 (HR=1.906) were related to the prognosis of gallbladder cancer (P<0.05). Kaplan-Meier analysis showed that the three-year overall survival rate (44.71%) of patients with 14-3-3θ positive expression was lower than that of patients with 14-3-3θ negative expression (71.43%) (Log Rank χ2=5.627, P=0.018). The three-year overall survival rate of TIMP3 positive expression patients (70.97%) was higher than that of TIMP3 negative expression patients (43.90%) (Log Rank χ2=6.130, P=0.013). Conclusion The positive expression rate of 14-3-3θ is higher in gallbladder cancer tissue, while the positive expression rate of TIMP3 is lower. The expression of 14-3-3θ and TIMP3 in gallbladder cancer tissue is closely related to the clinical pathological features and prognosis of patients.

Key words: Gallbladder cancer, Clinical pathological features, Prognosis, 14-3-3θ, Tissue inhibitors of metalloproteinase 3